Risultati della ricerca - Markowitz, M

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection di Markowitz M, Wang Y, Streaker E, Xiao X, Chen W, Haynes B

Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy di Lewin, S. R., Vesanen, M., Kostrikis, L., Hurley, A., Duran, M., Zhang, L., Ho, D. D., Markowitz, M.

Testo
Testo
Testo

Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. di Markowitz, M, Mo, H, Kempf, D J, Norbeck, D W, Bhat, T N, Erickson, J W, Ho, D D

Testo
Testo
Testo

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. di Binley, J M, Klasse, P J, Cao, Y, Jones, I, Markowitz, M, Ho, D D, Moore, J P

Testo
Testo
Testo

L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications. di Rosen, J F, Markowitz, M E, Bijur, P E, Jenks, S T, Wielopolski, L, Kalef-Ezra, J A, Slatkin, D N

Testo
Testo
Testo

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. di Patick, A K, Mo, H, Markowitz, M, Appelt, K, Wu, B, Musick, L, Kalish, V, Kaldor, S, Reich, S, Ho, D, Webber, S

Testo
Testo
Testo

0A06-01. Multiplicity of infection by HIV-1 in injection drug users, men who have sex with men and heterosexuals di Schumacher J, Markowitz M, Tremblay C, Chamberland A, Sun R, Grayson T, Keele B, Li H, Bar KJ, Hahn B, Shaw G

Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from Patients Treated with the Protease Inhibitor Nelfinavir di Patick, A. K., Duran, M., Cao, Y., Shugarts, D., Keller, M. R., Mazabel, E., Knowles, M., Chapman, S., Kuritzkes, D. R., Markowitz, M.

Testo
Testo
Testo

Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. di Poppe, S M, Slade, D E, Chong, K T, Hinshaw, R R, Pagano, P J, Markowitz, M, Ho, D D, Mo, H, Gorman, R R, Dueweke, T J, Thaisrivongs, S, Tarpley, W G

Testo
Testo
Testo

Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy di Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., Markowitz, M., Ho, D. D., McMichael, A. J., Nixon, D. F.

Testo
Testo
Testo

S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects di Markowitz M, Margolis DM, Shea TC, Kelsoe GH, Moody MA, Tomaras GD, Gao F, Yang Y, Marshalls DJ, Whitesides JF, Amos J, Parks R, Derosa K, Nagel A, Chen X, Dixon A, Liao H, Munshaw S, Goepfert P, Shaw G, Haynes BF, Kepler TB

P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI) di Denny T, Markowitz M, Shaw G, Margolis D, Shea T, Gao F, Yang Y, Amos J, Marshall D, Whitesides J, Mcparland M, Parks R, Derosa K, Foulger A, Nagel A, Zhang R, Moody M, Munshaw S, Dixon A, Chen X, Liao L, Kelsoe G, Tomaras G, Kepler T, Haynes B